Molecular Breast Imaging

Molecular Breast Imaging
Sponsored by the SNMMI Clinical Trials Network


Hannah Linden, MD; Gary Ulaner, MD, PhD

Course Summary
The purpose of this webinar is to increase clinical knowledge for nuclear medicine physicians, nuclear medicine technologists, and breast oncologists on molecular imaging agents for breast cancer. With the recent FDA approval of 18F-fluoroestradiol (FES) for breast cancer imaging, now is a great time to learn how molecular imaging can play a role in the management of breast cancer patients. Hannah Linden, a breast cancer specialist, will discuss this. Gary Ulaner will follow with a discussion on FES and HER2-targeted imaging

Course Learning Objectives
  • Identify the role of Molecular Breast Imaging in breast cancer management
  • Describe patient selection and utilization of FES in the clinic
  • Explain the rationale of using HER2-targeted imaging agentsin the study of breast cancer patients

CE Information
CE Credit applications for physicians, pharmacists, physicists and technologists are pending. Check back for updates regarding CE Credit status.
9/10/2020 3:00 PM - 4:00 PM

Register for Another Webinar

Sign In to Register